Expanding Access to Treatments through FDA’s NSURE Proposal
What are the benefits of improving available options for obtaining medications over the counter (OTC)? The US Food and Drug Administration (FDA) believes that there is great potential to improve outcomes in patients through improving their ability for self-care options, as well as addressing under- treatment in common disease processes. Regina Ballinger of Thomson Reuters discusses how the agency is continuing its investigation of the “Nonprescription Drug Safe Use Regulatory Expansion,” or NSURE programme, citing limitations in the OTC switch process currently used for marketing a product OTC.
http://jforcs.com/jcs/wp-content/uploads/2013/04/Expanding-Access-to-Treatments-Through-FDSs-NSURE-Proposal.pdf